The thermal chemistry of 1,3-diiodopropane on a Pt(111) single-crystal surface was investigated by temperature
programmed desorption (TPD) and reflection−absorption infrared spectroscopy (RAIRS). It was found that
the first decomposition steps of the chemisorbed diiodo compound are the scissions of its C−I bonds, and
that that takes place sequentially and results in the initial formation of an iodopropyl surface intermediate
which subsequently decomposes to a C3 metallacycle. Upon further heating of the crystal, the metallacycle
intermediate dehydrogenates via a β-hydride elimination step to form an allylic moiety. This allylic species
then hydrogenates to propene, a product that subsequently desorbs in two different temperature regimes (around
240 and 330 K) or dehydrogenates to surface propylidyne. The metallacyclic surface intermediate displays
additional chemistry at high coverages. Specifically, some of the hydrogen made available by β-hydride
elimination from a few of the C3 metallacycles is incorporated into other metallacycle moieties to form a
1-propyl intermediate. This 1-propyl group then undergoes β-hydride elimination to propene or hydrogenates
further to propane. Finally, the propene produced via 1-propyl dehydrogenation desorbs molecularly or
hydrogenates back to either 1- or 2-propyl intermediates. When 1,3-diiodopropane is coadsorbed with deuterium,
the dynamic propyl−propene interconversion results in extensive H−D exchange, yielding all possible
isotopomers of propene and propane. The implications of the overall complex hydrogenation−dehydrogenation
mechanism identified in this study to catalytic systems are discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.